Skip to content
value.today

TYBR Health, Inc.

🇺🇸 Houston, Texas, USABiotechnologyFounded 2020
Total raised
$21 M
2 rounds on record
Latest round
$14 M
Jul 2026
First round on record
Jan 2025
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of TYBR Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2026$14 MNo. 2$10 to $50 million

TYBR Health, Inc.: Raise no. 2, Jul 2026

Investors in this round

12 investors had bought by the notice of Jul 22, 2026: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $30 M offered; $16 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alex J. Smith · Executive Officer, Director
  • Timothy J. Keane Jr. · Executive Officer, Director
  • Aaron J. Smith · Director
  • Greg J. Banker · Director
  • Jeffrey J. Tyber · Director
  • Liz J. Zambory · Director
  • Toby J. Hamilton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Timothy J Keane Jr, Ceo. Newest notice filed Jul 22, 2026. Read the notice at the SEC.

equitySEC
Jan 2025$7 MNo. 1$2 to $10 million

TYBR Health, Inc.: Raise no. 1, Jan 2025

Investors in this round

50 investors had bought by the notice of Nov 26, 2025: 50 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Timothy J. Keane · Executive Officer, Director
  • Alex J. Smith · Director
  • Jeffrey J. Tyber · Director
  • Toby J. Hamilton · Director
  • Tom J. Dugan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “A portion of the Total Offering Amount and Total Amount Sold is comprised of the conversion of certain convertible securities previously issued by the Company.”

Signed by Timothy J. Keane, Chief Executive Officer. Newest notice filed Nov 26, 2025 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • TYBR Health, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2026).

    SEC Form D · Jul 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of TYBR Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by TYBR Health, Inc.
NameRoleNamed in
Alex J. SmithExecutive officerJul 2026
Timothy J. Keane Jr.Executive officerJul 2026
Timothy J. KeaneExecutive officerNov 2025
Timothy KeaneExecutive officerJan 2025
Aaron J. SmithDirectorJul 2026
Alex J. SmithDirectorJul 2026
Greg J. BankerDirectorJul 2026
Jeffrey J. TyberDirectorJul 2026
Liz J. ZamboryDirectorJul 2026
Timothy J. Keane Jr.DirectorJul 2026
Toby J. HamiltonDirectorJul 2026
Timothy J. KeaneDirectorNov 2025
Tom J. DuganDirectorNov 2025
Alex SmithDirectorJan 2025
Timothy KeaneDirectorJan 2025
Tom DuganDirectorJan 2025